SAB BIOTHERAPEUTICS, INC. (SABS) Debt Components
- 2025-12-31: Notes Payable, CurrentUSD $0.00; Notes PayableUSD (m); Debt Instrument, Periodic PaymentUSD (m); Notes Payable, Related Parties, CurrentUSD (m).
- 2025-09-30: Notes Payable, CurrentUSD $0.00; Notes PayableUSD (m); Debt Instrument, Periodic PaymentUSD (m); Notes Payable, Related Parties, CurrentUSD (m).
- 2025-06-30: Notes Payable, CurrentUSD $0.00; Notes PayableUSD (m); Debt Instrument, Periodic PaymentUSD (m); Notes Payable, Related Parties, CurrentUSD (m).
- 2025-03-31: Notes Payable, CurrentUSD $138.55K; Notes PayableUSD (m); Debt Instrument, Periodic PaymentUSD (m); Notes Payable, Related Parties, CurrentUSD (m).
SAB BIOTHERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Notes Payable USD | Debt Instrument, Periodic Payment USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|
| 2025-12-31 | $0.00 | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | (m) | (m) | (m) |
| 2025-03-31 | $138.55K | (m) | (m) | (m) |
| 2024-12-31 | $275.85K | (m) | (m) | (m) |
| 2024-12-31 | (m) | $275.85K | (m) | (m) |
| 2024-09-30 | $0.00 | (m) | (m) | (m) |
| 2024-06-30 | $615.82K | (m) | (m) | (m) |
| 2024-03-31 | $835.47K | (m) | (m) | (m) |
| 2023-12-31 | $1.05M | $1.05M | (m) | (m) |
| 2023-09-30 | $541.64K | (m) | (m) | (m) |
| 2023-06-30 | $111.89K | (m) | (m) | (m) |
| 2023-03-31 | $444.48K | (m) | (m) | (m) |
| 2022-12-31 | $772.66K | $1.31M | (m) | (m) |
| 2022-09-30 | $25.01K | (m) | (m) | (m) |
| 2022-06-30 | $278.44K | (m) | (m) | (m) |
| 2022-03-31 | $1.04M | (m) | (m) | (m) |
| 2021-12-31 | $1.80M | $1.80M | (m) | (m) |
| 2020-12-31 | $538.73K | $710.77K | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $150.00K |
| 2017-11-15 | (m) | (m) | $440.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |